Stifel Downgrades Atara Biotherapeutics to Hold, Lowers Price Target to $5

Cramer urged Wall Street to trust these influential figures, who he believes have consistently delivered positive results. He criticized the skeptics, stating, "It's the skeptics who've been wrong — the skeptics — year after year after darn year.